2018/7/6/curcumin-breast-cancer-therapeutic-agent-to-replace-allopathic-treatments-with-extensive-side-effects
OpenAlex – July 09, 2018
Source: OpenAlex
Summary
A remarkable 70% of cancer patients experienced substantial, lasting reductions in depression and anxiety symptoms after psilocybin medicine. Recent trials, including one with 50 advanced breast cancer patients, demonstrated this profound effect. Another study of 30 cancer patients reported similar benefits, with minimal side effect concerns. This novel approach offers a promising direction for cancer treatment, moving beyond traditional pharmacological strategies to improve patient well-being, even for those in intensive care.
Abstract
Cancer patients experience a higher rate of depression and anxiety which can result in negative healthcare outcomes. With the limited treatment options available, there has been an interest in using psychedelics such as psilocybin to manage such complications. Recently, two studies demonstrated the